New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
08:02 EDTLGND
theflyonthewall.com: Ligand Pharmaceuticals announces positive data from study on LGD-4033
Ligand Pharmaceuticals announced that data from a preclinical study on its selective androgen receptor modulator, or SARM, LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis. :theflyonthewall.com



News For LGND From The Last 14 Days
Check below for free stories on LGND the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2010
08:07 EDTLGND
theflyonthewall.com: Ligand Pharmaceuticals sees FY10 revenue $30M vs. consensus $34.61M.

Subscribe for More Information :theflyonthewall.com
08:06 EDTLGND
theflyonthewall.com: Ligand Pharmaceuticals reports Q4 EPS 1c vs. consensus of (2c)
Reports Q4 revenue $14M vs. consensus $7.97M. :theflyonthewall.com

January 28, 2010
09:03 EDTLGND
theflyonthewall.com: Ligand completes acquisition of Metabasis, gains partnership with Roche

Subscribe for More Information :theflyonthewall.com